Drug Search Results
More Filters [+]

Icosabutate

Alternative Names: icosabutate, prc-4016
Latest Update: 2024-02-21
Latest Update Note: News Article

Product Description

Mechanisms of Action: Fatty Acid Analogue

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pronova BioPharma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Icosabutate

Countries in Clinic: Puerto Rico, United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Fatty Liver, Alcoholic|Hepatitis, Alcoholic|Non-alcoholic Steatohepatitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ICONA

P2

Completed

Fatty Liver, Alcoholic|Hepatitis, Alcoholic|Non-alcoholic Steatohepatitis

2022-02-20

24%

Recent News Events